A&E
ActiveSummary
A&E has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of €630,513. Equity is growing by ~5.1% per year across the filed fiscal years. Its solvency ranks better than 70% of 2372 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability86▼-4
Solvency100=
Growth32▼-26
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €300,000 at 30 days acceptable
Liquidity ample (current ratio 4.97 against 7.68 in 2024; short-term debt: 20% and cash: 3.5% of total assets), and 20% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
80%
Return on assets
13.8%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-04-2026, 100 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
100 d early
2024
51 d early
2023
35 d early
2022
14 d early
2021
29 d late
2020
31 d late
2019
12 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 18 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 27 June (4 of the last 5 filed years within 63 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€3.6m▼ 3.2%
2024 · €3.8m
Total assets
€4.6m▲ 5.5%
2024 · €4.3m
Net result
€630,513▼ 14.4%
2024 · €736,423
Working capital
€3.6m▼ 2.7%
2024 · €3.7m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€789,668▼ 27.9%€1.1m▲ 37.8%€1.1m▼ 1.7%€963,825▼ 9.9%€758,407▼ 21.3%
Net result€594,242above the sector's middle half▼ 20.8%€742,332above the sector's middle half▲ 24.9%€763,465above the sector's middle half▲ 2.8%€736,423above the sector's middle half▼ 3.5%€630,513above the sector's middle half▼ 14.4%
Equity€3.1mabove the sector's middle half▲ 6.3%€3.4mabove the sector's middle half▲ 11.1%€3.5mabove the sector's middle half▲ 2.1%€3.8mabove the sector's middle half▲ 8.3%€3.6mabove the sector's middle half▼ 3.2%
Total assets€3.8mabove the sector's middle half▲ 5.5%€4.0mabove the sector's middle half▲ 4.5%€4.3mabove the sector's middle half▲ 6.9%€4.3mabove the sector's middle half▲ 0.6%€4.6mabove the sector's middle half▲ 5.5%
Debt€783,049▲ 2.8%€617,052▼ 21.2%€823,065▲ 33.4%€558,067▼ 32.2%€913,688▲ 63.7%
Working capital€3.0mabove the sector's middle half▲ 68.9%€3.3mabove the sector's middle half▲ 11.9%€3.4mabove the sector's middle half▲ 2.4%€3.7mabove the sector's middle half▲ 9.0%€3.6mabove the sector's middle half▼ 2.7%
Solvency79.6%within the sector's middle half▲ 0.5pp84.6%above the sector's middle half▲ 5.0pp80.8%within the sector's middle half▼ 3.8pp87.1%above the sector's middle half▲ 6.2pp80.0%within the sector's middle half▼ 7.1pp
Current ratio4.85within the sector's middle half▲ 1.536.47above the sector's middle half▲ 1.625.16within the sector's middle half▼ 1.317.68above the sector's middle half▲ 2.534.97within the sector's middle half▼ 2.71
Return on assets (ROA)15.5%within the sector's middle half▼ 5.1pp18.5%within the sector's middle half▲ 3.0pp17.8%within the sector's middle half▼ 0.7pp17.0%within the sector's middle half▼ 0.7pp13.8%within the sector's middle half▼ 3.2pp
Staff (FTE)0below the sector's middle half0below the sector's middle half0below the sector's middle half
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen three years in a row; 2025 is 21% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.6m
Fixed assets
€14,497 ▼ 58.6%
Current assets
€4.5m ▲ 6.0%
Equity and liabilities €4.6m
Equity
€3.6m ▼ 3.2%
Debt
€913,688 ▲ 63.7%
Debt's share of the balance-sheet total rises from 12.9% to 20.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€780,313▼
2024 · €985,463
Cash flow
€652,419▼
2024 · €758,061
Debt to equity
0.25▲
2024 · 0.15
ROE
17.3%▼
2024 · 19.6%
Interest coverage
2562.60▲
2024 · 306.15
Debt ≤ 1 year
€913,688▲
2024 · €558,067
Income taxes
€303,702▼
2024 · €351,991
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,134 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,134 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €330,483 | €0 | - | - | - | - |
| Remuneration, social security and pensions62 | - | - | €324 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €40,122 | €20,675 | €21,798 | €21,638 | €21,906 | ▲ 1.2% |
| Other operating charges640/8 | €128,983 | €2,377 | €1,161 | €1,514 | €1,316 | ▼ 13.0% |
| Non-recurring operating charges66A | €0 | - | - | - | - | - |
| Gross operating margin9900 | €958,773 | €1.1m | €1.1m | €986,977 | €781,629 | ▼ 20.8% |
| Operating profit (loss)9901 | €789,668 | €1.1m | €1.1m | €963,825 | €758,407 | ▼ 21.3% |
| Financial income75/76B | €19,125 | €24,910 | €71,923 | €127,808 | €176,113 | ▲ 37.8% |
| Recurring financial income75 | €19,125 | €24,910 | €71,923 | €127,808 | €176,113 | ▲ 37.8% |
| Financial charges65/66B | €10,901 | €17,913 | €2,004 | €3,219 | €305 | ▼ 90.5% |
| Recurring financial charges65 | €10,901 | €17,913 | €2,004 | €3,219 | €305 | ▼ 90.5% |
| Profit (loss) for the period before taxes9903 | €797,892 | €1.1m | €1.1m | €1.1m | €934,215 | ▼ 14.2% |
| Income taxes67/77 | €203,650 | €353,058 | €376,677 | €351,991 | €303,702 | ▼ 13.7% |
| Profit (loss) for the period9904 | €594,242 | €742,332 | €763,465 | €736,423 | €630,513 | ▼ 14.4% |
| Profit (loss) for the period to be appropriated9905 | €594,242 | €742,332 | €763,465 | €736,423 | €630,513 | ▼ 14.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €3.8m | €4.0m | €4.3m | €4.3m | €4.6m | ▲ 5.5% |
| Fixed assets21/28 | €84,658 | €68,125 | €53,289 | €34,998 | €14,497 | ▼ 58.6% |
| Tangible fixed assets22/27 | €84,658 | €68,125 | €47,713 | €29,422 | €8,921 | ▼ 69.7% |
| Land and buildings22 | €0 | - | - | - | - | - |
| Plant, machinery and equipment23 | €90 | €0 | - | - | - | - |
| Furniture and vehicles24 | €78,665 | €68,125 | €47,713 | €29,422 | €8,921 | ▼ 69.7% |
| Leasing and similar rights25 | €5,903 | - | - | - | - | - |
| Financial fixed assets28 | €0 | - | €5,576 | €5,576 | €5,576 | = |
| Current assets29/58 | €3.8m | €4.0m | €4.2m | €4.3m | €4.5m | ▲ 6.0% |
| Amounts receivable after more than one year29 | - | - | - | €251,400 | €421,838 | ▲ 67.8% |
| Other amounts receivable291 | - | - | - | €251,400 | €421,838 | ▲ 67.8% |
| Amounts receivable within one year40/41 | €3.0m | €2.4m | €3.9m | €3.7m | €3.9m | ▲ 3.1% |
| Trade receivables40 | €25,000 | €114,686 | €63,226 | €42,015 | €179,247 | ▲ 327% |
| Other amounts receivable41 | €3.0m | €2.3m | €3.8m | €3.7m | €3.7m | ▼ 0.6% |
| Current investments50/53 | - | - | €100,000 | €0 | - | - |
| Cash at bank and in hand54/58 | €536,745 | €1.4m | €126,567 | €135,093 | €158,407 | ▲ 17.3% |
| Deferred charges and accrued income490/1 | €185,341 | €177,578 | €146,203 | €163,087 | €111,068 | ▼ 31.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €3.8m | €4.0m | €4.3m | €4.3m | €4.6m | ▲ 5.5% |
| Equity10/15 | €3.1m | €3.4m | €3.5m | €3.8m | €3.6m | ▼ 3.2% |
| Contributions10/11 | €20,000 | €20,000 | €20,000 | €20,000 | €20,000 | = |
| Reserves13 | €3.0m | €3.3m | €3.4m | €3.7m | €3.6m | ▼ 3.2% |
| Non-distributable reserves130/1 | €198,797 | €198,797 | €196,942 | €196,942 | €196,942 | = |
| Reserves not available under the articles1311 | €198,797 | €198,797 | €196,942 | €196,942 | €196,942 | = |
| Distributable reserves133 | €2.8m | €3.1m | €3.2m | €3.5m | €3.4m | ▼ 3.4% |
| Profit (loss) carried forward14 | €43,941 | €43,941 | €43,941 | €43,941 | €43,941 | = |
| Amounts payable17/49 | €783,049 | €617,052 | €823,065 | €558,067 | €913,688 | ▲ 63.7% |
| Amounts payable within one year42/48 | €775,967 | €610,591 | €823,065 | €558,067 | €913,688 | ▲ 63.7% |
| Trade debts44 | €32,555 | €92,084 | €42,035 | €44,816 | €32,001 | ▼ 28.6% |
| Suppliers440/4 | €32,555 | €92,084 | €42,035 | €44,816 | €32,001 | ▼ 28.6% |
| Taxes, remuneration and social security45 | €27,364 | €112,861 | €125,160 | €88,560 | €168,663 | ▲ 90.4% |
| Taxes450/3 | €27,364 | €112,861 | €122,660 | €88,560 | €168,663 | ▲ 90.4% |
| Remuneration and social security454/9 | - | - | €2,500 | €0 | - | - |
| Other amounts payable47/48 | €716,047 | €405,646 | €655,869 | €424,690 | €713,024 | ▲ 67.9% |
| Accrued charges and deferred income492/3 | €7,082 | €6,461 | €0 | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €594,242 | €742,332 | €763,465 | €736,423 | €630,513 | ▼ 14.4% |
| + Depreciation and write-downs630 | €40,122 | €20,675 | €21,798 | €21,638 | €21,906 | ▲ 1.2% |
| Operating cash flow (approximation) | €634,364 | €763,007 | €785,262 | €758,061 | €652,419 | ▼ 13.9% |
| Investment in fixed assets (approximation) | - | -€4,142 | -€6,961 | -€3,347 | -€1,405 | ▲ 58.0% |
| Change in cash | - | €815,637 | -€1.2m | €8,526 | €23,313 | ▲ 173% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-04
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
10-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
26-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €763,465 ▲2.8%
Net result €763,465, the highest in the series.
17-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 29 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
12-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 12 days late
2019
31-12
Financial
Weakest financial yearnet €447,042 ▼35.2%
Net result drops to €447,042, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity times 140current ratio 2434.60
Current ratio from 17.42 to 2434.60; short-term debt falls from €180,298 to €1,058.
21-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 21 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 30 days late
2017
11-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genk · 1 establishment unit since 2003
Ground area
2,826 m²
Building footprint
156 m²
Volume, LiDAR
999 m³
Parcel 71016I1410/00Z047, Flanders · tallest building 9.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
A&E
since 20032.350.685.528
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71016I1410/00Z047 | Flanders | 2,826 m² | 1 · 156 m² | 9.5 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
RADIOLOGIE DR. SPRUYT
BE 0862.496.977
Wichelen · Eq €3,645,501
MAISON MEDICALE DUCHESSE
BE 0877.339.462
Sint-Jans-Molenbeek · Eq €3,658,566
DR. GERD FABRE
BE 0895.712.153
Roeselare · Eq €3,618,129
ARELIN
BE 0465.745.401
Ieper · Eq €3,598,127
DR. VERMANDER - DR. VAN IMSCHOOT
BE 0471.007.056
Brugge · Eq €3,590,330
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 3,239 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded03-04-1990
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0440535396
Registered
29-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.